Miller Anestesia

Bibliografía

1. Martyn JAJ, Fukushima Y, Chon JY, Yang S: Up-and-

down regulation of skeletal muscle acetylcholine

receptors. Intl Anesthesiol Clin 44:123, 2006.

2. Martyn JAJ, Richtsfeld M: Succinylcholine-induced

hyperkalemia in acquired pathologic states: Etiologic

factors and molecular mechanisms. Anesthesiology

104:158, 2006.

3. Martyn JAJ, White DA, Gronert GA, et al: Up-and

down-regulation of skeletal muscle acetylcholine

receptors. Anesthesiology 26:872, 1992.

4. Conti-Fine BM, Milani M, Kaminski HJ: Myasthenia

gravis: Past,present,and future.J Clin Invest 116:2843,

2006.

5. Vincent A, Dalton P, Clover L, et al: Antibodies to

neuronal targets in neurological and psychiatric

diseases. Ann N Y Acad Sci 992:48, 2003.

6. JohnsonWC,Prior C,Marshall IG: Presynaptic recep-

tors in the neuromuscular junction.Ann NYAcad Sci

604:69, 1990.

7. Fletcher GH, Steinbach JH: Ability of depolarizing

neuromuscular blocking drugs to act as partial ago-

nists at fetal and adult mouse muscle nicotinic recep-

tors. Mol Pharmacol 49:938, 1996.

8. Paul M, Kindler CH, Fokt RM, et al: Isobolographic

analysis of non-depolarising muscle relaxant interac-

tions at their receptor site. Eur J Pharmacol 438:35,

2002.

9. Jonsson M, Wyon N, Lindahl SGE: Neuromuscular

blocking agents block carotid body neuronal nicotinic

acetylcholine receptors. Eur J Pharmacol 497:173,

2004.

10. Jooste E, Zhang Y, Emala CW: Neuromuscular bloc-

king agents’ differential bronchoconstrictive potential

in Guinea pig airways. Anesthesiology 106:763, 2007.

11. Fryer AD, Maclagan J: Pancuronium and gallamine

are antagonists for pre- and post-junctional muscari-

nic receptors in the guinea-pig lung. Naunyn Schmie-

debergs Arch Pharmacol 335:367, 1987.

12. Lichtman JW, Conchello JA: Fluorescence micros-

copy. Nat Methods 2:910, 2005.

13. Kelly RB: The cell biology of the nerve terminal.

Neuron 1:431, 1988.

14. Kalamida D, Poulas K, Avramopoulou V, et al: Muscle

and neuronal nicotinic acetylcholine receptors: Struc-

ture, function and pathogenicity. FEBS Lett 274:3799,

2007.

15. Sanes JR, Lichtman JW: Induction, assembly, matura-

tion and maintenance of a postsynaptic apparatus.

Nat Rev Neurosci 2:791, 2001.

16. Bruneau EG, Akaaboune M: The dynamics of recy-

cled acetylcholine receptors at the neuromuscular

junction in vivo. Development 133:4485, 2006.

17. Cohen-Cory S: The developing synapse: Construction

and modulation of synaptic structures and circuits.

Science 298:770, 2002.

18. Aldunate R, Casar JC, Brandan E, Inestrosa NC:

Structural and functional organization of synaptic

acetylcholinesterase. Brain Res Brain Res Rev 47:96,

2004.

19. Song Y, Panzer JA, Wyatt RM, Balice-Gordon RJ:

Formation and plasticity of neuromuscular synaptic

connections. Int Anesthesiol Clin 44:145, 2006.

20. Fraterman S, Khurana TS, Rubinstein NA: Identifica-

tion of acetylcholine receptor subunits differentially

expressed in singly and multiply innervated fibers of

extraocular muscles. Invest Ophthalmol Vis Sci

47:3828, 2006.

21. Buttner-Ennever JA, Horn AK: Oculomotor system:

A dual innervation of the eye muscles from the abdu-

cens, trochlear, and oculomotor nuclei. Mov Disord

2:S2, 2002.

22. Durant NN, Katz RL: Suxamethonium. Br J Anaesth

54:195, 1982.

23. Vachon CA, Warner DO, Bacon DR: Succinylcholine

and the open globe. Tracing the teaching.Anesthesio-

logy 99:220, 2003.

24. Betz WJ, Caldwell JH, Kinnamon SC: Increased

sodium conductance in the synaptic region of rat

skeletal muscle fibers. J Physiol (Lond) 352:189,

1984.

25. Engel AG: The therapy of congenital myasthenic

syndromes. Neurotherapeutics 4:252, 2007.

26. Yu FH, Catterall WA: Overview of the voltage-gated

sodium channel family. Genome Biol 4:207, 2003.

27. Goudsouzian NG, Standaert FG: The infant and the

myoneural junction. Anesth Analg 65:1208, 1986.

28. Heuser JE, Reese TS: Structural changes after trans-

mitter release at the frog neuromuscular junction. J

Cell Biol 88:564, 1981.

29. Rash JE, Walrond JP, Morita M: Structural and func-

tional correlates of synaptic transmission in the verte-

brate neuromuscular junction. J Electron Microsc

Tech 10:153, 1988.

30. Sieburth D, Ch’ng Q, Dybbs M, et al: Systematic analy-

sis of genes required for synapse structure and func-

tion. Nature 436:510, 2005.

31. Naguib M, Flood P, McArdle JJ, Brenner HR: Advan-

ces in neurobiology of the neuromuscular junction:

Implications for the anesthesiologist. Anesthesiology

96:202, 2002.

32. Littleton JT, Sheng M: Neurobiology: Synapses

unplugged. Nature 424:931, 2003.

33. Hall Z, Merlie JR: Synaptic structure and develop-

ment: The neuromuscular junction. Cell 72:99, 1993.

34. Rich MM: The control of neuromuscular transmis-

sion in health and disease. Neuroscientist 12:134,

2006.

35. Wang X, Engisch KL, Li Y, et al: Decreased synaptic

activity shifts the calcium dependence of release at the

mammalian neuromuscular junction in vivo. J Neu-

rosci 24:10687, 2004.

36. Ryan AM, Matthews E, Hanna MG: Skeletal-muscle

channelopathies: Periodic paralysis and nondystrop-

hic myotonias. Curr Opin Neurol 20:558, 2007.

37. Katz B, Miledi R: Estimates of quantal content during

“chemical potentiation” of transmitter release. Proc R

Soc Lond [Biol] 215:369, 1979.

38. Uchitel OD, Protti DA, Sanchez V, et al: P-type voltage

dependent calcium channel mediates presynaptic

calcium influx and transmitter release in mammalian

synapses. Proc Natl Acad Sci U S A 89:3330, 1992.

39. Vincent A: Immunology of disorders of neuromuscu-

lar transmission. Acta Neurol Scand Suppl 183:1,

2006.

40. Sudhof TC: Synaptic vesicles: An organelle comes of

age. Cell 127:671, 2006.

41. Rizolli SO, Betz WJ: All change at the synapse. Nature

423:591, 2003.

42. Lang T, Jahn R: Core proteins of the secretory machi-

nery. Handb Exp Pharmacol 184:107, 2008.

43. Valtorta F, Jahn R, Fesce R, et al: Synaptophysin (p38)

at the frog neuromuscular junction: Its incorporation

into the axolemma and recycling after intense quantal

secretion. J Cell Biol 107:2717, 1988.

44. Heidelberger R: Neuroscience: Sensors and synchro-

nicity. Nature 450:623, 2007.

45. Turton K, Chaddock JA, Acharya KR: Botulinum

and tetanus neurotoxins: Structure, function and

therapeutic utility. Trends Biochem Sci 27:552,

2002.

46. Schiavo G: Structural biology: Dangerous liaisons on

neurons. Nature 444:1019, 2006.

47. Schurch B: The role of botulinum toxin in neurouro-

logy. Drugs Today (Barc) 40:205, 2004.

48. Lowe NJ: Overview of botulinum neurotoxins. J

Cosmet Laser Ther 9(Suppl 1)11, 2007.

49. Frick CG, Richtsfeld M, Martyn JAJ, et al: Long-term

effects of botulinum toxin on neuromuscular func-

tion. Anesthesiology 106:1139, 2007.

50. Lange DJ, Rubin M, Gelb DJ, et al: Distant effects of

locally injected botulinum toxin: A double-blind

study of single fiber EMG changes. Muscle Nerve

14:672, 1991.

51. Heeroma JH,Plomp JJ,Roubos EW,Verhage M: Deve-

lopment of the mouse neuromuscular junction in the

absence of regulated secretion. Neuroscience 120:733,

2003.

52. Engel AG, Ohno K, Sine SM: Congenital myasthenic

syndromes: Progress over the past decade. Muscle

Nerve 27:4, 2003.

53. Engel AG, Sine SM: Current understanding of

congenital myasthenic syndromes. Curr Opin Phar-

macol 5:308, 2005.

54. Abraham RB, Rudick V, Weinbroum AA: Practical

guidelines for acute care of victims of bioterrorism:

Conventional injuries and concomitant nerve agent

intoxication. Anesthesiology 97:989, 2002.

55. Karwa M,Currie B,KvetanV: Bioterrorism: Preparing

for the impossible or the improbable. Crit Care Med

33:S75, 2005.

56. Gu Y, Forsayeth JR, Verall S: Assembly of the mam-

malian muscle acetylcholine receptor in transfected

COS cells. J Cell Biol 114:799, 1991.

57. Kopta C, Steinbach JH: Comparison of mammalian

adult and fetal nicotinic acetylcholinic receptors

stably expressed in fibroblasts. J Neurosci 14:3922,

1994.

58. Jonsson M, Gulrey D, Dabrowski M, et al: Distinct

pharmacologic properties of neuromuscular blocking

agents on human neuronal nicotinic acetylcholine

receptors: A possible explanation for the train-of-four

fade. Anesthesiology 105:521, 2006.

59. Jonsson M, Dabrowski M, Gurley DA, et al:Activation

and inhibition of human muscular and neuronal

nicotinic acetylcholine receptors by succinylcholine.

Anesthesiology 104:724, 2006.

60. Pedersen SE, Cohen JB: D-Tubocurarine binding sites

are located at alpha-gamma and alpha-delta subunit

interfaces of the nicotinic acetylcholine receptor. Proc

Natl Acad Sci U S A 87:2785, 1990.

61. Griesmann GE, McCormick DJ, De Aizpurua HJ, et

al:

-Bungarotoxin binds to human acetylcholine

receptor

-subunit peptide 185-199. J Neurochem

54:1541, 1990.

62. Escher P, Lacazette E, Courtet M, et al: Synapses form

in skeletal muscles lacking neuregulin receptors.

Science 308:1920, 2005.

63. Gullberg D: Cell biology: The molecules that make

muscle. Nature 424:138, 2003.

64. Missias AC, Chu GC, Klocke BJ, et al: Maturation of

the acetylcholine receptor in skeletal muscle: Regula-

tion of the AChR

-to-

switch. Dev Biol 179:223,

1996.

65. Tansey MG, Chu GC, Merlie JP: ARIA/HRG regulates

AChR epsilon subunit gene expression at the neuro-

muscular synapse via activation of phosphatidylino-

sitol 3-kinase and Ras/MAPK pathway. J Cell Biol

134:46, 1996.

66. Lukas RJ, Bencherif M: Heterogeneity and regulation

of nicotinic acetylcholine receptors. Int Rev Neuro-

biol 34:25, 1992.

67. McCarthy MP, Stroud RM: Conformational states of

the nicotinic acetylcholine receptor from

Torpedo

californica

induced by the binding of agonist, antago-

nists, and local anesthetics. Equilibrium measure-

mentsusingtritium-hydrogenexchange.Biochemistry

28:40, 1989.

68. Karlin A, DiPaola M, Kao PN, Lobel P: Functional

sites and transient states of the nicotinic acetylcholine

receptor. In Hille B, Fambrough DM (eds): Proteins

of Excitable Membranes. Society of General Physio-

logists. New York, Wiley Interscience, 1987, pp 43.

69. Yamaoka K, Vogel SM, Seyama I: Na

channel phar-

macology and molecular mechanisms of gating. Curr

Pharm Des 12:429, 2006.

70. Raines DE: Anesthesia and nonanesthetic volatile

compounds have dissimilar activities on nicotinic

acetylcholine receptor desensitization kinetics. Anes-

thesiology 84:663, 1996.

71. Sine SM: The nicotinic receptor ligand binding

domain. J Neurobiol 53:431, 2002.

72. Gage PW: Ion channels and postsynaptic potentials.

Biophys Chem 29:951, 1988.

73. Gage PW, Hammill OP: Effects of anesthetics on ion

channels in synapses. Int Rev Neurophysiol 25:3, 1981.

74. Swope SL, Qu Z, Huganir RL: Phosphorylation of

nicotinic acetylcholine receptor by protein tyrosine

kinases. Ann N Y Acad Sci 757:197, 1995.

75. Plested CP, Tang T, Spreadbury I, et al: AChR

phosphorylation and indirect inhibition of AChR

Sección I

Fisiología y anestesia

Fisiología y farmacología neuromusculares

125